Ran Nussbaum - Mar 25, 2021 Form 4/A - Amendment Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Mar 25, 2021
Transactions value $
$5,150
Form type
4/A - Amendment
Date filed
6/9/2021, 01:46 PM
Date Of Original Report
Apr 22, 2021
Previous filing
Nov 30, 2022
Next filing
May 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $5.15K +1.03K +0.07% $5.00* 1.43M Mar 25, 2021 Managing Partner of entities affiliated with Pontifax Management III G.P. ( F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -1.03K -100% $0.00* 0 Mar 25, 2021 Ordinary Shares 1.03K $5.00 By Pontifax Cayman III Limited Partnership F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021.